Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -69.48%.However, over the last six months, we can see a stronger performance of -70.56%. Over the last 30 days, the price of LIMN has leaped by -59.78%. And in the last five days, it has fallen by -15.80%.
Liminatus Pharma Inc experienced a somewhat shaky performance in the stock market.
52-week price history of LIMN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Liminatus Pharma Inc’s current trading price is -90.34% away from its 52-week high, while its distance from the 52-week low is 28.46%. The stock’s price range during this period has varied between$2.53 and $33.66. The Liminatus Pharma Inc’s shares, which operate in the Healthcare, saw a trading volume of around 0.92 million for the day, a figure considerably lower than their average daily volume of 1.25 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Liminatus Pharma Inc (LIMN) has experienced a quarterly decline of -35.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 87.96M and boasts a workforce of 3 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
LIMN Stock Stochastic Average
Liminatus Pharma Inc’s raw stochastic average for the past 50 days is presently 2.31%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 15.75%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 15.11% and 10.78%, respectively.
